Identification of the naturally occurring genes encoding carbapenem-hydrolysing oxacillinases from Acinetobacter haemolyticus, Acinetobacter johnsonii, and Acinetobacter calcoaceticus

Clinical Microbiology and Infection

Volumn 18, Issue 9, 2012, Pages 907-913

  Figueiredo, S ^a,b   Bonnin, R A ^a   Poirel, L ^a   Duranteau, J ^b   Nordmann, P ^a  

^a Associated French National Reference Center for Antibiotic Resistance: Carbapenemase producing Enterobacteriaceae   (France)

^b BICÊTRE HOSPITAL   (France)

Author keywords

Carbapenem resistance; CHDL; Gram negative rods; Specific activity

Indexed keywords

AMINO ACID; BACTERIAL ENZYME; BETA LACTAMASE; CARBAPENEM; CARBAPENEM HYDROLYSING OXACILLINASE; PENICILLIN G; UNCLASSIFIED DRUG;

ACINETOBACTER; ACINETOBACTER BAUMANNII; ACINETOBACTER CALCOACETICUS; ACINETOBACTER HAEMOLYTICUS; ACINETOBACTER JOHNSONII; ACINETOBACTER LWOFFII; ACINETOBACTER RADIORESISTENS; AMINO ACID SEQUENCE; ARTICLE; BACTERIAL GENE; BACTERIAL GENOME; BACTERIAL STRAIN; CONTROLLED STUDY; GENE IDENTIFICATION; GENE SEQUENCE; HYDROLYSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ACINETOBACTER; ACINETOBACTER BAUMANNII; ACINETOBACTER CALCOACETICUS; ACINETOBACTER HAEMOLYTICUS; ACINETOBACTER JOHNSONII; ACINETOBACTER LWOFFII; ACINETOBACTER RADIORESISTENS; NEGIBACTERIA;

EID: 84862507880     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2011.03708.x     Document Type: Article

References (20)

1. Espinal P, Roca I, Vila J. Clinical impact and molecular basis of antimicrobial resistance in non-baumannii Acinetobacter. Future Microbiol 2011; 6: 495-511.
2. Castellanos Martinez E, Telenti Asensio M, Rodriguez Blanco VM, Rodriguez Suarez ML, Morena Torrico A, Cortina Llosa A. Infective endocarditis of an interventricular patch caused by Acinetobacter haemolyticus. Infection 1995; 23: 243-245.
3. Grotiuz G, Sirok A, Gadea P, Varela G, Schelotto F. Shiga toxin 2-producing Acinetobacter haemolyticus associated with a case of bloody diarrhea. J Clin Microbiol 2006; 44: 3838-3841.
4. Seifert H, Strate A, Schulze A, Pulverer G. Vascular catheter-related bloodstream infection due to Acinetobacter johnsonii (formerly Acinetobacter calcoaceticus var. lwoffi): report of 13 cases. Clin Infect Dis 1993; 17: 632-636.
5. Doughari HJ, Ndakidemi PA, Human IS, Benade S. The ecology, biology and pathogenesis of Acinetobacter spp.: an overview. Microbes Environ 2011; 26: 101-112.
6. Lambert T, Gerbaud G, Galimand M, Courvalin P. Characterization of Acinetobacter haemolyticus aac(6′)-ig gene encoding an aminoglycoside 6′-N-acetyltransferase which modifies amikacin. Antimicrob Agents Chemother 1993; 37: 2093-2100.
7. Quinteira S, Grosso F, Ramos H, Peixe L. Molecular epidemiology of imipenem resistant Acinetobacter haemolyticus and Acinetobacter baumannii isolates carrying plasmid-mediated OXA-40 from a Portuguese hospital. Antimicrob Agents Chemother 2007; 51: 3465-3466.
8. Figueiredo S, Poirel L, Seifert H, Mugnier P, Benhamou D, Nordmann P. OXA-134, a naturally occurring carbapenem-hydrolyzing class D β-lactamase from Acinetobacter lwoffii. Antimicrob Agents Chemother 2010; 54: 5372-5375.
9. Héritier C, Poirel L, Fournier PE, Claverie JM, Raoult D, Nordmann P. Characterization of the naturally occurring oxacillinase of Acinetobacter baumannii. Antimicrob Agents Chemother 2005; 49: 4174-4179.
10. Poirel L, Figueiredo S, Cattoir V, Carattoli A, Nordmann P. Acinetobacter radioresistens as a silent source of carbapenem resistance for Acinetobacter spp. Antimicrob Agents Chemother 2008; 52: 1252-1256.
11. Mugnier PD, Poirel L, Naas T, Nordmann P. Worldwide dissemination of the blaOXA-23 carbapenemase gene of Acinetobacter baumannii. Emerg Infect Dis 2010; 16: 35-40.
12. Nemec A, Krizova L, Maixnerova M et al. Genotypic and phenotypic characterization of the Acinetobacter calcoaceticus-Acinetobacter baumannii complex with the proposal of Acinetobacter pittii sp. nov. (formerly Acinetobacter genomic species 3) and Acinetobacter nosocomialis sp. nov. (formerly Acinetobacter genomic species 13TU). Res Microbiol 2011; 162: 393-404.
13. Nemec A, Musílek M, Sedo O et al. Acinetobacter bereziniae sp. nov. and Acinetobacter guillouiae sp. nov., to accommodate Acinetobacter genomic species 10 and 11, respectively. Int J Syst Evol Microbiol 2010; 60: 896-903.
14. Dortet L, Legrand P, Soussy CJ, Cattoir V. Bacterial identification, clinical significance, and antimicrobial susceptibilities of Acinetobacter ursingii and Acinetobacter schindleri, two frequently misidentified opportunistic pathogens. J Clin Microbiol 2006; 44: 4471-4478.
15. Bonnin RA, Nordmann P, Potron A, Lecuyer H, Zahar JR, Poirel L. Carbapenem hydrolyzing GES-type extended-spectrum β-lactamase in Acinetobacter baumannii. Antimicrob Agents Chemother 2011; 55: 349-354.
16. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; 21st informational supplement. CLSI M100-S21. Wayne, PA: CLSI, 2011.
17. Poirel L, Guibert M, Girlich D, Naas T, Nordmann P. Cloning, sequence analyses, expression, and distribution of ampC-ampR from Morganella morganii clinical isolates. Antimicrob Agents Chemother 1999; 43: 769-776.
18. Fournier PE, Vallenet D, Barbe V et al. PLoS Genet 2006; 2: e7.
19. Couture F, Lachapelle J, Levesque RC. Phylogeny of LCR-1 and OXA-5 with class A and class D β-lactamases. Mol Microbiol 1992; 6: 1693-1705.
20. Poirel L, Naas T, Nordmann P. Diversity, epidemiology, and genetics of class D β-lactamases. Antimicrob Agents Chemother 2010; 54: 24-38.